Press Release
11 May 2023
Cellular Origins Partners With ScaleReady to Simplify, Standardize, and Automate Cell Therapy Manufacturing
Partnership aims to integrate ScaleReady’s CGT manufacturing workflow with Cellular Origins’ robotic technology
Initially focussed on automation of ScaleReady’s G-Rex platform
1 March 2023
Bio-Techne Announces Investment in Wilson Wolf
Bio-Techne Corporation announced Wilson Wolf Manufacturing has met the trailing 12-month earnings before interest, taxes, depreciation, and amortization (EBITDA) target...26 April 2022
Marker Therapeutics Announces Entry into Services Agreement with Wilson Wolf
HOUSTON, April 26, 2022 (GLOBE NEWSWIRE) -- -- Marker Therapeutics, Inc. (Nasdaq: MRKR), a clinical-stage immuno-oncology company specializing in the...14 December 2021
Bio-Techne Announces Future Wilson Wolf Purchase Agreement
Bio-Techne announced it has entered into a purchase option agreement with Wilson Wolf Corporation, solidifying resources and support for ScaleReady...10 November 2021
ScaleReady Launches Second Generation of Wilson Wolf G-Rex Product
The second generation G-Rex500M-CS improves on the materials and ergonomics of the original G-Rex while retaining the same cell expansion...3 November 2021
Bio-Techne Releases First GMP-grade Cytokines from New GMP Facility
ScaleReady sources Bio-Techne cytokines because of their commitment to supplying the entire cell and gene therapy industry with GMP-grade, animal...2 June 2021
ScaleReady hosts ISCT Symposium on Intelligent Scale-up
ScaleReady recruited a prestigious panel of cell therapy manufacturing experts to discuss their experiences and strategies for commercial scale up...6 January 2021
ScaleReady Launches
ScaleReady launches with the mission to make cell and gene therapy manufacturing practical and viable. Through a partnership between Bio-Techne,...21 January 2020